NDC 63020-400
NINLARO
Ixazomib
NINLARO is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Millennium Pharmaceuticals, Inc.. The primary component is Ixazomib Citrate.
| Product ID | 63020-400_099668ff-d75a-4d4c-870b-834d89e3bd69 |
| NDC | 63020-400 |
| Product Type | Human Prescription Drug |
| Proprietary Name | NINLARO |
| Generic Name | Ixazomib |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-11-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208462 |
| Labeler Name | Millennium Pharmaceuticals, Inc. |
| Substance Name | IXAZOMIB CITRATE |
| Active Ingredient Strength | 4 mg/1 |
| Pharm Classes | Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 63020-400-02
3 BLISTER PACK in 1 CARTON (63020-400-02) > 1 CAPSULE in 1 BLISTER PACK (63020-400-01)
| Marketing Start Date | 2015-11-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 63020-400-01 [63020040001]
NINLARO CAPSULE
| Marketing Category | NDA |
| Application Number | NDA208462 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-11-20 |
NDC 63020-400-02 [63020040002]
NINLARO CAPSULE
| Marketing Category | NDA |
| Application Number | NDA208462 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-11-20 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| IXAZOMIB CITRATE | 4 mg/1 |
OpenFDA Data
| SPL SET ID: | 038f2461-834b-4488-9ebd-863c83eef5a7 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Proteasome Inhibitor [EPC]
- Proteasome Inhibitors [MoA]
NDC Crossover Matching brand name "NINLARO" or generic name "Ixazomib"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 63020-078 | NINLARO | ixazomib |
| 63020-079 | NINLARO | ixazomib |
| 63020-080 | NINLARO | ixazomib |
| 63020-230 | NINLARO | ixazomib |
| 63020-390 | NINLARO | ixazomib |
| 63020-400 | NINLARO | ixazomib |
Trademark Results [NINLARO]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NINLARO 85854620 4905454 Live/Registered |
Millennium Pharmaceuticals, Inc. 2013-02-20 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.